TY  - RPRT
TI  - Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer.
AU  - F A Holmes
AU  - J A O'Shaughnessy
AU  - S Vukelja
AU  - S E Jones
AU  - J Shogan
AU  - M Savin
AU  - J Glaspy
AU  - M Moore
AU  - L Meza
AU  - I Wiznitzer
AU  - T A Neumann
AU  - L R Hill
AU  - B C Liang
PY  - 2002
DO  - 10.1200/jco.2002.20.3.727
UR  - https://pubmed.ncbi.nlm.nih.gov/11821454/
ID  - 11821454
ER  -